ARS Pharmaceuticals (SPRY) Total Non-Current Liabilities (2021 - 2026)
ARS Pharmaceuticals (SPRY) reported Total Non-Current Liabilities of $233.58 million for Q2 2026, up 95.1% from $119.73 million a year earlier and up 5.3% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, ARS Pharmaceuticals posted Total Non-Current Liabilities of $208.79 million, up 121.3% from FY2024.
- Total Non-Current Liabilities has a four-year compound annual growth rate of 22.5% (FY2021 to FY2025).
- By year, Total Non-Current Liabilities came in at $94.36 million in FY2024, $8.55 million in FY2022 (-90.8%) and $92.63 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at $221.79 million (Q1 2026), $208.79 million (Q4 2025) and $221.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | 233.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 233.58 Mn |
| Mar 31, 2026 | 221.79 Mn |
| Dec 31, 2025 | 208.79 Mn |
| Sep 30, 2025 | 221.37 Mn |
| Jun 30, 2025 | 119.73 Mn |
| Dec 31, 2024 | 94.36 Mn |
| Dec 31, 2022 | 8.55 Mn |
| Dec 31, 2021 | 92.63 Mn |
API Access
ARS Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();